How mRNA Technology Gave Us the First COVID-19 Vaccines | Time
Swiss Medical Weekly - The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination
ge.ch
UK firm to trial T-cell Covid vaccine that could give longer immunity | Vaccines and immunisation | The Guardian
Frontiers | RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics? | Immunology
Vaccines | Free Full-Text | Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans | HTML
mRNA vaccine - Wikipedia
Pharmaceutics | Free Full-Text | Opportunities and Challenges in the Delivery of mRNA-Based Vaccines | HTML
Vaccines | Free Full-Text | An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
Vaccines | Free Full-Text | mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients | HTML
Design und Funktionsweise von mRNA-basierten Impfstoffen zum Schutz vor Infektionskrankheiten (COVID-19-Update) - Trillium GmbH Medizinischer Fachverlag
How vaccine technology, choice and supply work in Switzerland - SWI swissinfo.ch
Behind the Science: what is an mRNA Vaccine? | Pfizer UK
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland - ScienceDirect
BNT162b2 mRNA COVID-19 Vaccine: First Approval | SpringerLink
4 things about mRNA COVID vaccines researchers still want to find out | Gavi, the Vaccine Alliance
Swiss Medical Weekly - The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination
Switzerland backs mRNA vaccine for booster jabs - SWI swissinfo.ch
Protection duration after vaccination or infection – Swiss National COVID-19 Science Task Force
Swiss Medical Weekly - Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran – a clinical case and global pharmacovigilance data
Protection duration after vaccination or infection – Swiss National COVID-19 Science Task Force
BNT162b2 mRNA COVID-19 Vaccine: First Approval | SpringerLink
How do mRNA vaccines work? | Covid-19 vaccination explained
4 things about mRNA COVID vaccines researchers still want to find out | Gavi, the Vaccine Alliance
Will an mRNA vaccine alter my DNA? | Gavi, the Vaccine Alliance
Vaccines | Free Full-Text | An Update on Self-Amplifying mRNA Vaccine Development | HTML
Clinical and Experimental Pediatrics
Vaccines | Free Full-Text | SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond | HTML
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies | Nature
